Denmark

 

HBI News Round Up, 14th June 2024

In this HBI News Round Up, we look at Denmark’s new rules for foreign healthcare workers, healthcare-focused PE fund Tata Capital Healthcare Fund’s multi-million investment into pharma firm Orbicular Pharmaceutical to develop its R&D work, the awarding of a multi-million diabetes treatments contract to American pharma and medical devices group Abbott in Cantabria, Spain, and a partnership in Spain to establish a rare diseases research centre.
June 14, 2024

New entrants could disrupt “tough” fertility market

The cost-of-living crisis is having a huge impact on fertility patients, making the sector ripe for disruption. A fertility expert tells HBI cunning new entrants will be the winners while established PE could well be the losers.
January 26, 2024

New AI act could stifle EU innovation – but benefit the UK

After 38 hours of deliberation, a long-awaited deal has finally been reached in Brussels. HBI speaks to three market experts to understand what the AI Act - the comprehensive European framework for AI innovation and regulation - could mean for the future of healthcare in Europe.
December 15, 2023

Eugin sells for €500m

Healthcare conglomerate Fresenius has sold Eugin, its Spain-based fertility business, to KKR-owned fertility group IVI RMA and Spain-based asset management firm GED for €500m including earn-outs.
November 10, 2023

Interview – Ingeborg Oie, CFO and Chief Strategy Officer, Huma 

In this wide ranging interview we discuss the future of remote patient monitoring (RPM) software and government progress in ehealth. Through its RPM platform,  Huma claims to massively cut costs and improve outcomes for patients with chronic conditions.
August 16, 2023

HBI 2023: Managing your costs in challenging times

Rising costs from inflation, wages, and energy are indiscriminately hitting the health care sector and despite government support packages being pledged, the road ahead looks arduous. So how do providers control costs, and what are the strategies to keep costs at bay?
July 15, 2023

Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.
March 17, 2023
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us